These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28263461)

  • 1. Current Concepts in Methadone Metabolism and Transport.
    Kharasch ED
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):125-134. PubMed ID: 28263461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2004 Sep; 76(3):250-69. PubMed ID: 15371986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of HIV antiretrovirals on methadone N-demethylation and transport.
    Campbell SD; Gadel S; Friedel C; Crafford A; Regina KJ; Kharasch ED
    Biochem Pharmacol; 2015 May; 95(2):115-25. PubMed ID: 25801005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantiomeric metabolic interactions and stereoselective human methadone metabolism.
    Totah RA; Allen KE; Sheffels P; Whittington D; Kharasch ED
    J Pharmacol Exp Ther; 2007 Apr; 321(1):389-99. PubMed ID: 17259447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.
    Gerber JG; Rhodes RJ; Gal J
    Chirality; 2004 Jan; 16(1):36-44. PubMed ID: 14628297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Methadone Metabolism by CYP2B6 Variants.
    Gadel S; Friedel C; Kharasch ED
    Drug Metab Dispos; 2015 Jul; 43(7):994-1001. PubMed ID: 25897175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of efavirenz influence on methadone pharmacokinetics and pharmacodynamics.
    Kharasch ED; Whittington D; Ensign D; Hoffer C; Bedynek PS; Campbell S; Stubbert K; Crafford A; London A; Kim T
    Clin Pharmacol Ther; 2012 Apr; 91(4):673-84. PubMed ID: 22398970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone Pharmacogenetics: CYP2B6 Polymorphisms Determine Plasma Concentrations, Clearance, and Metabolism.
    Kharasch ED; Regina KJ; Blood J; Friedel C
    Anesthesiology; 2015 Nov; 123(5):1142-53. PubMed ID: 26389554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cytochrome P4502B6 in methadone metabolism and clearance.
    Kharasch ED; Stubbert K
    J Clin Pharmacol; 2013 Mar; 53(3):305-13. PubMed ID: 23361846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Drug Interaction Studies of Methadone and Antiviral Drugs: Lessons Learned.
    Younis IR; Lakota EA; Volpe DA; Patel V; Xu Y; Sahajwalla CG
    J Clin Pharmacol; 2019 Aug; 59(8):1035-1043. PubMed ID: 30973652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics of methadone: clinical and forensic toxicological implications and variability of dose response.
    Dinis-Oliveira RJ
    Drug Metab Rev; 2016 Nov; 48(4):568-576. PubMed ID: 27320437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokkar M; Gothuey I; Hämmig R; Monnat M; Hüttemann H; Baumann P; Eap CB
    Clin Pharmacol Ther; 2005 Dec; 78(6):593-604. PubMed ID: 16338275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.
    Levran O; Peles E; Hamon S; Randesi M; Adelson M; Kreek MJ
    Addict Biol; 2013 Jul; 18(4):709-16. PubMed ID: 21790905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis.
    Dennis BB; Bawor M; Thabane L; Sohani Z; Samaan Z
    PLoS One; 2014; 9(1):e86114. PubMed ID: 24489693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity.
    Kharasch ED; Walker A; Whittington D; Hoffer C; Bedynek PS
    Drug Alcohol Depend; 2009 May; 101(3):158-68. PubMed ID: 19232844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone N-demethylation by the common CYP2B6 allelic variant CYP2B6.6.
    Gadel S; Crafford A; Regina K; Kharasch ED
    Drug Metab Dispos; 2013 Apr; 41(4):709-13. PubMed ID: 23298862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCB1, CYP2B6, and CYP3A4 genetic polymorphisms do not affect methadone maintenance treatment in HCV-positive patients.
    Sutlović D; Ključević Ž; Kuret S
    Arh Hig Rada Toksikol; 2020 Dec; 71(4):353-358. PubMed ID: 33410778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone pharmacogenetics in vitro and in vivo: Metabolism by CYP2B6 polymorphic variants and genetic variability in paediatric disposition.
    Wang PF; Sharma A; Montana M; Neiner A; Juriga L; Reddy KN; Tallchief D; Blood J; Kharasch ED
    Br J Clin Pharmacol; 2022 Nov; 88(11):4881-4893. PubMed ID: 35538637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic modeling of R and S-Methadone and their metabolites to study the effects of various covariates in post-operative children.
    Aruldhas BW; Quinney SK; Overholser BR; Heathman MA; Masters AR; Ly RC; Gao H; Packiasabapathy S; Sadhasivam S
    CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1183-1194. PubMed ID: 34435753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CYP2B6 in stereoselective human methadone metabolism.
    Totah RA; Sheffels P; Roberts T; Whittington D; Thummel K; Kharasch ED
    Anesthesiology; 2008 Mar; 108(3):363-74. PubMed ID: 18292673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.